1. Home
  2. NVO
  3. NVO News

Latest Novo Nordisk A/S (NVO) News on June 1, 2025

Hims to cut 4% of workforce amid ban on weight-loss drug copies
NVO

Reuters

2 days ago

Hims to cut 4% of workforce amid ban on weight-loss drug copies

2 Top Stocks to Buy With Less Than $100
NVO

Motley Fool

2 days ago

2 Top Stocks to Buy With Less Than $100

2 Beaten-Down Stocks to Buy on the Dip
NVO

Motley Fool

2 days ago

2 Beaten-Down Stocks to Buy on the Dip

How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race
NVO

Quartz

2 days ago

How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race

Was Jim Cramer Right About Eli Lilly and Company (LLY)?
NVO

Insider Monkey

3 days ago

Was Jim Cramer Right About Eli Lilly and Company (LLY)?

Meet the New Group of Weight-Loss Drugs. The Industry Is Betting Big on Amylin.
NVO

Barrons.com

3 days ago

Meet the New Group of Weight-Loss Drugs. The Industry Is Betting Big on Amylin.

Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli Lilly
NVO

Investor's Business Daily

3 days ago

Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli Lilly

How Ozempic’s Maker Lost Its Grip on the Obesity Market It Created
NVO

The Wall Street Journal

4 days ago

How Ozempic’s Maker Lost Its Grip on the Obesity Market It Created

GLP-1 prescriptions for weight loss are shooting up, despite obstacles
NVO

Healthcare Dive

4 days ago

GLP-1 prescriptions for weight loss are shooting up, despite obstacles

Novo Nordisk's 52% Plunge: Is the Company Fumbling Its Leadership in the $150 Billion Weight Loss Market?
NVO

Motley Fool

4 days ago

Novo Nordisk's 52% Plunge: Is the Company Fumbling Its Leadership in the $150 Billion Weight Loss Market?

Jim Cramer Notes Eli Lilly (LLY) Stock is at a “Decent Level to Start a Position”
NVO

Insider Monkey

5 days ago

Jim Cramer Notes Eli Lilly (LLY) Stock is at a “Decent Level to Start a Position”

Novo Nordisk vs. Viking Therapeutics: Which GLP-1 Stock Has More Upside?
NVO

Zacks

5 days ago

Novo Nordisk vs. Viking Therapeutics: Which GLP-1 Stock Has More Upside?

3 Surprising Stocks That Have More Than Doubled in 2025
NVO

Motley Fool

5 days ago

3 Surprising Stocks That Have More Than Doubled in 2025

Why Novo Nordisk Stock Just Popped
NVO

Motley Fool

5 days ago

Why Novo Nordisk Stock Just Popped

Prothena's Late-Stage Study for AL Amyloidosis Fails, Stock Down
NVO

Zacks

5 days ago

Prothena's Late-Stage Study for AL Amyloidosis Fails, Stock Down

Here is What to Know Beyond Why Novo Nordisk A/S (NVO) is a Trending Stock
NVO

Zacks

6 days ago

Here is What to Know Beyond Why Novo Nordisk A/S (NVO) is a Trending Stock

Why Hims & Hers Health Stock (HIMS) Is Too Hot to Handle
NVO

TipRanks

8 days ago

Why Hims & Hers Health Stock (HIMS) Is Too Hot to Handle

NVO

MT Newswires

9 days ago

European Equities Close Sharply Lower in Friday Trading; German Q1 GDP Expands 0.4% Sequentially

3 Stocks Targeting Weight Loss Market With Cannabinoid-Based Therapies
NVO

Zacks

9 days ago

3 Stocks Targeting Weight Loss Market With Cannabinoid-Based Therapies

NVO

MT Newswires

9 days ago

Novo Nordisk Receives Positive Opinion From EU Committee on Extension of Saxenda Indication

Americans scramble as weight-loss drug discounts fall short, copies face crackdown
NVO

Reuters

9 days ago

Americans scramble as weight-loss drug discounts fall short, copies face crackdown

Pharma Stock Roundup: NVO CEO Resigns, SNY to Buy VIGL & More
NVO

Zacks

9 days ago

Pharma Stock Roundup: NVO CEO Resigns, SNY to Buy VIGL & More

Cigna Announced a New Agreement for Copay Caps on Eli Lilly and Novo Nordisk Weight Loss Drugs
NVO

Insider Monkey

10 days ago

Cigna Announced a New Agreement for Copay Caps on Eli Lilly and Novo Nordisk Weight Loss Drugs

Bitcoin soars, Fannie Mae & Freddie Mac, Novo's GLP-1 discount
NVO

Yahoo Finance Video

10 days ago

Bitcoin soars, Fannie Mae & Freddie Mac, Novo's GLP-1 discount

Novo Nordisk battles Wegovy copycats through discounted prices, legal threats
NVO

Yahoo Finance

10 days ago

Novo Nordisk battles Wegovy copycats through discounted prices, legal threats

NVO

MT Newswires

10 days ago

LifeMD, Novo Nordisk Collaborate on Discounted Wegovy Bundle

New Novo Nordisk initiatives support patient access to authentic, FDA-approved Wegovy® as federal ban on mass compounding of "semaglutide" takes effect
NVO

PR Newswire

10 days ago

New Novo Nordisk initiatives support patient access to authentic, FDA-approved Wegovy® as federal ban on mass compounding of "semaglutide" takes effect

Did Eli Lilly Just Say Checkmate to Novo Nordisk?
NVO

Motley Fool

10 days ago

Did Eli Lilly Just Say Checkmate to Novo Nordisk?

BMO Capital Maintains Cautious Outlook on Novo Nordisk Amid CEO Transition
NVO

Insider Monkey

11 days ago

BMO Capital Maintains Cautious Outlook on Novo Nordisk Amid CEO Transition

Novo Nordisk Places Bet on CEO Shake-Up to Reclaim Edge in Weight Loss Drug Race
NVO

Insider Monkey

12 days ago

Novo Nordisk Places Bet on CEO Shake-Up to Reclaim Edge in Weight Loss Drug Race

Noom is offering smaller doses of compounded Wegovy for weight loss
NVO

Quartz

12 days ago

Noom is offering smaller doses of compounded Wegovy for weight loss

Why Novo Nordisk Stock Popped on Tuesday
NVO

Motley Fool

12 days ago

Why Novo Nordisk Stock Popped on Tuesday

Novo Nordisk Woes Just Hit Denmark’s Economy. The Stock Is Rising.
NVO

Barrons.com

12 days ago

Novo Nordisk Woes Just Hit Denmark’s Economy. The Stock Is Rising.

NVO

MT Newswires

12 days ago

Sector Update: Health Care Stocks Flat to Higher Premarket Tuesday

What Makes Novo Nordisk (NVO) a Lucrative Investment?
NVO

Insider Monkey

12 days ago

What Makes Novo Nordisk (NVO) a Lucrative Investment?

NVO

MT Newswires

12 days ago

Sector Update: Health Care

Novo Nordisk, Charter & Cox, Take Two: Trending Tickers
NVO

Yahoo Finance Video

16 days ago

Novo Nordisk, Charter & Cox, Take Two: Trending Tickers

Novo Nordisk's CEO is out after the Ozempic maker's stock dropped 50% in a year
NVO

Quartz

16 days ago

Novo Nordisk's CEO is out after the Ozempic maker's stock dropped 50% in a year

NVO

MT Newswires

16 days ago

Sector Update: Health Care Stocks Flat to Higher Premarket Friday

CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down in wake of share price drop
NVO

Associated Press Finance

16 days ago

CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down in wake of share price drop

Novo Nordisk CEO steps down in surprise move as 'market challenges' weigh on obesity drugmaker
NVO

Yahoo Finance

16 days ago

Novo Nordisk CEO steps down in surprise move as 'market challenges' weigh on obesity drugmaker

Instant View: Wegovy-maker Novo Nordisk ousts CEO as competition in obesity drug market heats up
NVO

Reuters

16 days ago

Instant View: Wegovy-maker Novo Nordisk ousts CEO as competition in obesity drug market heats up

5 Things to Know Before the Stock Market Opens
NVO

Investopedia

16 days ago

5 Things to Know Before the Stock Market Opens

Novo Nordisk Says CEO to Step Down Amid Stock Slump. The Shares Are Down 5%.
NVO

Barrons.com

16 days ago

Novo Nordisk Says CEO to Step Down Amid Stock Slump. The Shares Are Down 5%.

Eli Lilly Shares Tumble After Rival Novo?Nordisk Strikes Major Weight Loss Deal
NVO

GuruFocus.com

18 days ago

Eli Lilly Shares Tumble After Rival Novo?Nordisk Strikes Major Weight Loss Deal

Stock Market Today: Dow Jones Slips As Nvidia Takes Apple's Crown; AMD Shoots Higher (Live Coverage)
NVO

Investor's Business Daily

18 days ago

Stock Market Today: Dow Jones Slips As Nvidia Takes Apple's Crown; AMD Shoots Higher (Live Coverage)

Novo Nordisk Inks A Major Obesity Deal, Sending Shares Of New Partner Septerna Skyrocketing
NVO

Investor's Business Daily

18 days ago

Novo Nordisk Inks A Major Obesity Deal, Sending Shares Of New Partner Septerna Skyrocketing

NVO

MT Newswires

18 days ago

Sector Update: Health Care Stocks Fall Late Afternoon

eToro's Nasdaq debut, Exelixis outlook, Septerna–Novo deal
NVO

Yahoo Finance Video

18 days ago

eToro's Nasdaq debut, Exelixis outlook, Septerna–Novo deal

NVO

MT Newswires

18 days ago

Sector Update: Health Care Stocks Lower in Afternoon Trading

Novo Nordisk taps Septerna in $2.2bn deal for oral obesity therapies
NVO

Pharmaceutical Technology

18 days ago

Novo Nordisk taps Septerna in $2.2bn deal for oral obesity therapies

Healthcare worst-performing S&P 500 subsector year to date: Mizuho expert
NVO

Yahoo Finance

18 days ago

Healthcare worst-performing S&P 500 subsector year to date: Mizuho expert

Novo Nordisk, Septerna sign $2.2B deal to develop weight-loss pill
NVO

Yahoo Finance Video

18 days ago

Novo Nordisk, Septerna sign $2.2B deal to develop weight-loss pill

Novo Nordisk's latest bet on obesity pills: $2.2 billion for biotech Sapterna
NVO

Yahoo Finance

18 days ago

Novo Nordisk's latest bet on obesity pills: $2.2 billion for biotech Sapterna

NVO

MT Newswires

18 days ago

Sector Update: Health Care Stocks Rise Premarket Wednesday

NVO

MT Newswires

18 days ago

Sector Update: Health Care

Lilly Down 17% Since Q1 Results: Should You Buy the Dip in LLY Stock?
NVO

Zacks

18 days ago

Lilly Down 17% Since Q1 Results: Should You Buy the Dip in LLY Stock?

NVO

MT Newswires

18 days ago

Novo Nordisk, Septerna to Collaborate on Oral Small Molecule Obesity Medicines

Novo Nordisk strikes $2.2 billion deal with Septerna to develop new obesity treatments
NVO

Reuters

18 days ago

Novo Nordisk strikes $2.2 billion deal with Septerna to develop new obesity treatments

Trump's drug price order is part request, part threat: Analyst
NVO

Yahoo Finance Video

20 days ago

Trump's drug price order is part request, part threat: Analyst

S&P, Dow Pharma Stocks Boomerang On Drug-Pricing Order That Is 'All Bark' And 'Little Bite'
NVO

Investor's Business Daily

20 days ago

S&P, Dow Pharma Stocks Boomerang On Drug-Pricing Order That Is 'All Bark' And 'Little Bite'

Trump calls out weight-loss drugs as target of price-cut push
NVO

Reuters

20 days ago

Trump calls out weight-loss drugs as target of price-cut push

How Trump could go about executing order to slash drug prices
NVO

Yahoo Finance Video

20 days ago

How Trump could go about executing order to slash drug prices

Novo Nordisk’s Sogroya matches Norditropin in children’s growth disorders
NVO

Clinical Trials Arena

20 days ago

Novo Nordisk’s Sogroya matches Norditropin in children’s growth disorders

Fox One, SoftBank delays investment, Zepbound weight loss
NVO

Yahoo Finance Video

20 days ago

Fox One, SoftBank delays investment, Zepbound weight loss

Trump expected to sign order to slash US drug prices
NVO

Yahoo Finance Video

20 days ago

Trump expected to sign order to slash US drug prices

Novo Nordisk Stock Is Slumping Today. Here’s Why.
NVO

Barrons.com

20 days ago

Novo Nordisk Stock Is Slumping Today. Here’s Why.

Novo Nordisk's Sogroya Supports Effective Weekly Alternative To Daily Hormone Therapy Across Three Growth Disorders
NVO

Benzinga

20 days ago

Novo Nordisk's Sogroya Supports Effective Weekly Alternative To Daily Hormone Therapy Across Three Growth Disorders

Novo Nordisk Tumbles as Lilly's Zepbound Shows Greater Weight Loss in Trial
NVO

GuruFocus.com

20 days ago

Novo Nordisk Tumbles as Lilly's Zepbound Shows Greater Weight Loss in Trial

Novo Nordisk A/S: Once-weekly Sogroya® (somapacitan) is an efficacious and well-tolerated long-acting growth hormone in children with growth disorders: results from REAL8 phase 3 basket study presented at the joint Congress of ESPE and ESE
NVO

GlobeNewswire

20 days ago

Novo Nordisk A/S: Once-weekly Sogroya® (somapacitan) is an efficacious and well-tolerated long-acting growth hormone in children with growth disorders: results from REAL8 phase 3 basket study presented at the joint Congress of ESPE and ESE

Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial
NVO

Reuters

21 days ago

Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial

Is Novo Nordisk (NVO) the Best Stock to Buy According to Jim Simons’ Renaissance Technologies?
NVO

Insider Monkey

21 days ago

Is Novo Nordisk (NVO) the Best Stock to Buy According to Jim Simons’ Renaissance Technologies?

Pharma Stock Roundup: NVO & JAZZ's Q1 Results, AZN's Pipeline Update
NVO

Zacks

23 days ago

Pharma Stock Roundup: NVO & JAZZ's Q1 Results, AZN's Pipeline Update

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
NVO

GlobeNewswire

23 days ago

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

Superb Quarterly Report Opens Door to $100 Price Target on Hims & Hers Health Stock (HIMS)
NVO

TipRanks

23 days ago

Superb Quarterly Report Opens Door to $100 Price Target on Hims & Hers Health Stock (HIMS)

Currency hedging and new U.S. factories: Novo Nordisk CFO thinks Wegovy maker can outmaneuver global trade wars
NVO

Fortune

23 days ago

Currency hedging and new U.S. factories: Novo Nordisk CFO thinks Wegovy maker can outmaneuver global trade wars

Novo Nordisk (NVO) Upgraded to Buy: Here's What You Should Know
NVO

Zacks

24 days ago

Novo Nordisk (NVO) Upgraded to Buy: Here's What You Should Know

Novo Nordisk (NVO) is a Top Dividend Stock Right Now: Should You Buy?
NVO

Zacks

24 days ago

Novo Nordisk (NVO) is a Top Dividend Stock Right Now: Should You Buy?

Does Novo Nordisk (NVO) Have the Potential to Rally 51.24% as Wall Street Analysts Expect?
NVO

Zacks

24 days ago

Does Novo Nordisk (NVO) Have the Potential to Rally 51.24% as Wall Street Analysts Expect?

Down Nearly 20%: Should You Buy the Dip on Eli Lilly?
NVO

Motley Fool

24 days ago

Down Nearly 20%: Should You Buy the Dip on Eli Lilly?

Novo Nordisk AS (NVO) Q1 2025 Earnings Call Highlights: Robust Growth Amid Challenges
NVO

GuruFocus.com

24 days ago

Novo Nordisk AS (NVO) Q1 2025 Earnings Call Highlights: Robust Growth Amid Challenges

These Stocks Moved the Most Today: Alphabet, Nvidia, Super Micro, Marvell, Disney, Uber, Arista, Sarepta, Charles River, and More
NVO

Barrons.com

25 days ago

These Stocks Moved the Most Today: Alphabet, Nvidia, Super Micro, Marvell, Disney, Uber, Arista, Sarepta, Charles River, and More

Novo Nordisk Blames Compounders As It Cuts 2025 Forecast. But Shares Jump.
NVO

Investor's Business Daily

25 days ago

Novo Nordisk Blames Compounders As It Cuts 2025 Forecast. But Shares Jump.

Stock market today: Dow, S&P 500, Nasdaq rise as Fed holds rates steady, Powell sticks to 'wait and see'
NVO

Yahoo Finance

25 days ago

Stock market today: Dow, S&P 500, Nasdaq rise as Fed holds rates steady, Powell sticks to 'wait and see'

NVO

MT Newswires

25 days ago

Sector Update: Health Care Stocks Rise Late Afternoon

NVO

MT Newswires

25 days ago

Sector Update: Health Care Stocks Gain Wednesday Afternoon

3 major takeaways from Novo Nordisk's Q1 earnings
NVO

Yahoo Finance Video

25 days ago

3 major takeaways from Novo Nordisk's Q1 earnings

Novo Nordisk Predicts Strong Second Half
NVO

Motley Fool

25 days ago

Novo Nordisk Predicts Strong Second Half

NVO

MT Newswires

25 days ago

Sector Update: Health Care Stocks Advance Pre-Bell Wednesday

Novo Blames Compounders As It Cuts 2025 Forecast. Shares Jump.
NVO

Investor's Business Daily

25 days ago

Novo Blames Compounders As It Cuts 2025 Forecast. Shares Jump.

NVO

MT Newswires

25 days ago

Sector Update: Health Care

Novo Nordisk Shares Jump 6% as Wegovy Fuels Double-Digit Growth
NVO

GuruFocus.com

25 days ago

Novo Nordisk Shares Jump 6% as Wegovy Fuels Double-Digit Growth

5 Things to Know Before the Stock Market Opens
NVO

Investopedia

25 days ago

5 Things to Know Before the Stock Market Opens

Novo Nordisk cuts 2025 outlook due to compounding-hit Wegovy demand
NVO

Pharmaceutical Technology

25 days ago

Novo Nordisk cuts 2025 outlook due to compounding-hit Wegovy demand

These Stocks Are Moving the Most Today: Super Micro, AMD, Disney, Uber, Novo Nordisk, Sarepta, EA, Tesla, and More
NVO

Barrons.com

25 days ago

These Stocks Are Moving the Most Today: Super Micro, AMD, Disney, Uber, Novo Nordisk, Sarepta, EA, Tesla, and More

Top 1% Stock, Hims & Hers Health, Dives On Lackluster Outlook
NVO

Investor's Business Daily

a month ago

Top 1% Stock, Hims & Hers Health, Dives On Lackluster Outlook

Novo Nordisk A/S: ECO 2025 - Novo Nordisk semaglutide data shows new health benefits across serious chronic diseases
NVO

GlobeNewswire

a month ago

Novo Nordisk A/S: ECO 2025 - Novo Nordisk semaglutide data shows new health benefits across serious chronic diseases

Inside Last Week's Wall Street Rally & Best-Performing ETF Areas
NVO

Zacks

a month ago

Inside Last Week's Wall Street Rally & Best-Performing ETF Areas

Best-Performing Leveraged ETFs of Last Week
NVO

Zacks

a month ago

Best-Performing Leveraged ETFs of Last Week

Hims & Hers Health Inc (HIMS) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ...
NVO

GuruFocus.com

a month ago

Hims & Hers Health Inc (HIMS) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ...

Share on Social Networks: